BR112015002739A2 - métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferos - Google Patents
métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferosInfo
- Publication number
- BR112015002739A2 BR112015002739A2 BR112015002739A BR112015002739A BR112015002739A2 BR 112015002739 A2 BR112015002739 A2 BR 112015002739A2 BR 112015002739 A BR112015002739 A BR 112015002739A BR 112015002739 A BR112015002739 A BR 112015002739A BR 112015002739 A2 BR112015002739 A2 BR 112015002739A2
- Authority
- BR
- Brazil
- Prior art keywords
- mammals
- health
- function
- cognitive
- decline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261681414P | 2012-08-09 | 2012-08-09 | |
PCT/US2013/054274 WO2014026081A1 (en) | 2012-08-09 | 2013-08-09 | Plant extracts for improving cognitive health and function |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015002739A2 true BR112015002739A2 (pt) | 2017-07-04 |
Family
ID=50066333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015002739A BR112015002739A2 (pt) | 2012-08-09 | 2013-08-09 | métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20140044813A1 (pt) |
EP (1) | EP2882443B1 (pt) |
JP (3) | JP2015524484A (pt) |
KR (1) | KR101947352B1 (pt) |
CN (2) | CN111358832A (pt) |
AU (1) | AU2013299491B2 (pt) |
BR (1) | BR112015002739A2 (pt) |
CA (1) | CA2880708C (pt) |
ES (1) | ES2715005T3 (pt) |
PL (1) | PL2882443T3 (pt) |
WO (1) | WO2014026081A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015116920A1 (en) * | 2014-01-30 | 2015-08-06 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
WO2016044299A1 (en) * | 2014-09-15 | 2016-03-24 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
MX2017004582A (es) * | 2014-10-08 | 2017-10-12 | Abbott Lab | Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua. |
JP2020508962A (ja) * | 2016-11-11 | 2020-03-26 | ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. | 神経新生の促進を通して脳の健康を改善するための植物抽出物の使用 |
CN106727915B (zh) * | 2017-01-18 | 2020-03-31 | 云南德彩堂生物医药科技有限公司 | 一种稳定高效提高记忆的组合物及其制备方法和应用 |
CA3080578A1 (en) * | 2017-10-30 | 2019-05-09 | Neuropore Therapies, Inc. | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
CN109602759B (zh) * | 2019-01-17 | 2020-10-09 | 广西医科大学 | 罗汉松实多糖的用途 |
KR102421772B1 (ko) * | 2019-05-21 | 2022-07-18 | 건국대학교 글로컬산학협력단 | 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물 |
CN110463846A (zh) * | 2019-07-30 | 2019-11-19 | 河南科技学院 | 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用 |
JP7330630B2 (ja) * | 2019-11-20 | 2023-08-22 | 株式会社ニップン | ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1219509C (zh) * | 1998-05-16 | 2005-09-21 | 财团法人牧岩生命工学研究所 | 迷迭香酸及其衍生物用于制备免疫抑制剂药物的用途 |
JP4629822B2 (ja) * | 1999-12-02 | 2011-02-09 | 長瀬産業株式会社 | 神経成長因子合成促進剤 |
JP2006199666A (ja) * | 2005-01-24 | 2006-08-03 | Nagase & Co Ltd | 健忘症の予防・治療剤 |
AU2006304787A1 (en) * | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
EP1925213A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses |
EP1930019A1 (en) * | 2006-11-24 | 2008-06-11 | DSMIP Assets B.V. | Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
WO2008090474A2 (en) * | 2007-01-24 | 2008-07-31 | University Of Guelph | Production of rosmarinic acid from spearmint and uses thereof |
US7972633B2 (en) * | 2007-02-07 | 2011-07-05 | Applied Cognitive Sciences, LLC | Nutritional supplements for healthy memory and mental function |
EP2060192B9 (en) * | 2007-10-17 | 2016-05-04 | Rudolf Wild GmbH & Co. KG | Composition comprising lemon balm extracts |
JP5892928B2 (ja) * | 2009-06-12 | 2016-03-23 | ジェネレックス ファーマシューティカルズ インコーポレイテッド | 赤血球凝固の予防及び治療のための組成物並びに方法 |
CN101773488A (zh) * | 2010-02-10 | 2010-07-14 | 青岛大学 | 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用 |
JP2011256118A (ja) * | 2010-06-07 | 2011-12-22 | Kao Corp | Il−8及びgm−csf発現抑制剤 |
-
2013
- 2013-08-08 US US13/962,609 patent/US20140044813A1/en active Pending
- 2013-08-09 CN CN202010406999.5A patent/CN111358832A/zh active Pending
- 2013-08-09 JP JP2015526726A patent/JP2015524484A/ja active Pending
- 2013-08-09 BR BR112015002739A patent/BR112015002739A2/pt not_active Application Discontinuation
- 2013-08-09 PL PL13828399T patent/PL2882443T3/pl unknown
- 2013-08-09 CA CA2880708A patent/CA2880708C/en active Active
- 2013-08-09 WO PCT/US2013/054274 patent/WO2014026081A1/en active Application Filing
- 2013-08-09 AU AU2013299491A patent/AU2013299491B2/en active Active
- 2013-08-09 KR KR1020157006128A patent/KR101947352B1/ko active IP Right Grant
- 2013-08-09 ES ES13828399T patent/ES2715005T3/es active Active
- 2013-08-09 EP EP13828399.9A patent/EP2882443B1/en active Active
- 2013-08-09 CN CN201380051858.4A patent/CN104684562A/zh active Pending
-
2021
- 2021-01-08 JP JP2021001953A patent/JP2021066735A/ja active Pending
-
2022
- 2022-12-09 JP JP2022196766A patent/JP2023027232A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2015524484A (ja) | 2015-08-24 |
CA2880708C (en) | 2023-09-26 |
WO2014026081A1 (en) | 2014-02-13 |
CA2880708A1 (en) | 2014-02-13 |
JP2021066735A (ja) | 2021-04-30 |
CN111358832A (zh) | 2020-07-03 |
EP2882443B1 (en) | 2019-01-16 |
US20140044813A1 (en) | 2014-02-13 |
AU2013299491A1 (en) | 2015-02-12 |
EP2882443A1 (en) | 2015-06-17 |
JP2023027232A (ja) | 2023-03-01 |
KR20150041654A (ko) | 2015-04-16 |
ES2715005T3 (es) | 2019-05-31 |
EP2882443A4 (en) | 2016-01-06 |
CN104684562A (zh) | 2015-06-03 |
PL2882443T3 (pl) | 2019-06-28 |
KR101947352B1 (ko) | 2019-02-12 |
AU2013299491B2 (en) | 2018-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015002739A2 (pt) | métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferos | |
BR112014031436A2 (pt) | comparar e substituir entrada de tabela dat | |
BR112015004100A2 (pt) | aparelho, método, e, mídia legível por computador não temporária | |
BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
BR302013001738S1 (pt) | Configuração aplicada em mobiliário. | |
BR112014031806A2 (pt) | método para tratamento de câncer positivo para gd2 | |
BR302013000148S1 (pt) | Configuração aplicada em estojo de utensílios. | |
FI20125045L (fi) | Menetelmä ja hissijärjestely | |
EP2944323A4 (en) | MEANS FOR THE TREATMENT OF TUMORS, USE AND METHOD THEREFOR | |
BR112015007975A2 (pt) | processo para preparar continuamente tetrapolímeros, e tetrapolímero | |
BR112014031693A2 (pt) | método, e, ferramenta. | |
BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
BR112014030159A2 (pt) | agente para tratamento de floculação. | |
BR302013000531S1 (pt) | Configuração aplicada em banheira. | |
BR112015005036A2 (pt) | válvula de gás-lift, e método | |
BR302012006416S1 (pt) | Configuração aplicada em traquéia para dispositivos de inalação. | |
BR112015004419A2 (pt) | artigo e método. | |
BR112014032290A2 (pt) | composições e métodos para tratar ou prevenir infecção de pneumovírus e doenças associadas. | |
BR112015005088A2 (pt) | composição catalisadora, e , processo de oxicloração de etileno | |
BR112014026536A2 (pt) | processo e composição. | |
BR112014028461A2 (pt) | placa de gesso, e, método para fabricar placa de gesso | |
EP2846796A4 (en) | METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION | |
BR112015013877A2 (pt) | método, e, composição | |
ZA201404986B (en) | Methods for preventing, treating or diagnosing disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |